ARHGEF35 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.73825448163734E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.03961325396085E-13 |
Normal-vs-Stage2 |
2.50359999398597E-09 |
Normal-vs-Stage3 |
3.35287353436797E-14 |
Normal-vs-Stage4 |
4.31876756579186E-14 |
Stage1-vs-Stage2 |
9.904000E-01 |
Stage1-vs-Stage3 |
9.971600E-02 |
Stage1-vs-Stage4 |
9.167900E-02 |
Stage2-vs-Stage3 |
2.987200E-01 |
Stage2-vs-Stage4 |
3.131800E-01 |
Stage3-vs-Stage4 |
9.960000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.37587727269783E-14 |
Normal-vs-AfricanAmerican |
5.50139933608307E-11 |
Normal-vs-Asian |
5.614400E-01 |
Caucasian-vs-AfricanAmerican |
6.653400E-01 |
Caucasian-vs-Asian |
4.533800E-02 |
AfricanAmerican-vs-Asian |
5.260400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.63979940737136E-12 |
Normal-vs-Female |
3.7265746044568E-12 |
Male-vs-Female |
3.993900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.43310000053776E-07 |
Normal-vs-Age(41-60Yrs) |
4.96269692007445E-14 |
Normal-vs-Age(61-80Yrs) |
3.51385587293862E-13 |
Normal-vs-Age(81-100Yrs) |
5.0776000004582E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.896800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.692000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.033400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.533000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.515600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.208800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.823500E-03 |
Normal-vs-Grade 2 |
2.11786144177495E-12 |
Normal-vs-Grade 3 |
1.63624669369256E-12 |
Normal-vs-Grade 4 |
4.30150359775894E-11 |
Grade 1-vs-Grade 2 |
2.976200E-01 |
Grade 1-vs-Grade 3 |
7.508000E-02 |
Grade 1-vs-Grade 4 |
3.333800E-01 |
Grade 2-vs-Grade 3 |
1.284440E-01 |
Grade 2-vs-Grade 4 |
6.696600E-01 |
Grade 3-vs-Grade 4 |
6.892400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
9.26925203259543E-13 |
Normal-vs-ccB subtype |
1.19826371047793E-12 |
ccA subtype-vs-ccB subtype |
7.021400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.75792713719147E-12 |
Normal-vs-N1 |
1.420180E-04 |
N0-vs-N1 |
8.033800E-01 |
|
|